ALKS vs XRAY · P/E 14, rev $1.56B vs rev $3.68B
Alkermes Plc (ALKS) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the ALKS and XRAY stock pages for the full models.
Not investment advice.